Akoya Biosciences, Inc. announced the appointment of Jennifer Kamocsay as General Counsel. Ms. Kamocsay will oversee all company legal activities and provide strategic guidance and corporate governance oversight. Ms. Kamocsay most recently served as General Counsel of Rubius Therapeutics, Inc., where she was responsible for overseeing and managing all of the company's legal affairs.

Prior to joining Rubius, she was Associate General Counsel for Progress Software Corporation where she oversaw the company's corporate, securities law, and mergers and acquisitions activities. Ms. Kamocsay began her legal career at the law firm of Skadden, Arps, Slate, Meagher & Flom LLP, where she represented public and private company clients in the biotechnology and pharmaceutical industries on mergers and acquisitions, securities law, and corporate governance matters. Ms. Kamocsay holds a B.A. in History from the University of California, Los Angeles and a J.D. from Northeastern University School of Law.